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Summary
BackgroundWe recently reported that repair following mechanical wounding of epithelial cell
layers in vitro is dependent on fibrin formation and the activity of locally expressed
coagulation cascade proteins. Serine proteases of the coagulation cascade are an important
group of protease-activated receptor (PAR) activators and PAR-1 to 4 are expressed by the
normal bronchial epithelium.
Objective We tested the hypothesis that activation of PAR-1 and PAR-2 by coagulation
cascade proteases stimulates epithelial repair via effects on fibrin formation.
Methods Using mechanically wounded 16HBE 14o epithelial cell layers in culture, we
investigated the effect of PAR-1 and PAR-2 agonist peptides, control partially scrambled
peptides and PAR-neutralizing antibodies on the rate of repair and fibrin formation.
Coagulation factors in culture supernatants were measured by immunoblot. RT-PCR was used
to investigate PAR-1, PAR-2 and PGE2 receptor (EP-1 to EP-4) expression in this model and
qRT-PCR to quantify responses to wounding. Additionally, we investigated the effect of
exogenously added factor Xa (FXa) and neutrophil elastase and the influence of PGE2 and
indomethacin on the repair response.
Results PAR-1 and PAR-2 peptide agonists stimulated the rate of repair and enhanced the
formation of a fibrin provisional matrix to support the repair process. Conversely, PAR-
neutralizing antibodies inhibited repair. Under serum-free culture conditions, 16HBE
14o cells expressed EP-2 and EP-3, but not EP-1 or EP-4, receptors. Wounding induced an
increased expression of EP-3 but did not alter EP-2, PAR-1 or PAR-2 expression. In the
absence of PAR agonists, there was no evidence for a role for PGE2 in fibrin formation or the
repair process. Indomethacin attenuated fibrin formation in wounded cultures only in the
presence of the PAR-2 peptide. FXa stimulated epithelial repair while neutrophil elastase
reduced the levels of coagulation factors and inhibited repair.
Conclusion Locally expressed serine proteases of the coagulation cascade activate PAR-1 and
PAR-2 to enhance fibrin formation and bronchial epithelial repair.
Keywords bronchial epithelium, coagulation, elastase, factor Xa, fibrin, protease-activated
receptor
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Introduction
The normal airway epithelium provides a physical barrier
to the invasion of lung tissue by inhaled foreign particles,
including pollutants, allergens, bacteria and viruses. To-
gether with chemical and cellular mechanisms of the
innate immune system, this physical barrier maintains
sterility in the lower airways [1, 2]. Proteolytic activity
associated with inhaled mites, fungi, pollen and bacteria
damages the airway epithelium [3–5] and induces an
inflammatory response that contributes to the develop-
ment of a number of respiratory diseases, including
asthma and rhinitis, in susceptible individuals, but not in
healthy subjects with the same level of exposure [5].
Despite the potential of inhaled particles to damage the
airway epithelium, the normal bronchial epithelium
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remains relatively intact and continuous repair of this
tissue is indicated. Animal models have demonstrated that
bronchial epithelial repair is dependent on the rapid
formation of a fibrin gel [3] and it was postulated that this
was entirely dependent on plasma-derived coagulation
factors [6]. However, we recently reported that repair
following mechanical wounding of bronchial epithelial
cell layers in vitro is similarly dependent on rapid fibrin
formation, but critically dependent on the activity of
locally expressed coagulation cascade proteins [7].
The protease-activated receptors (PARs) are a family of
four widely expressed G-protein coupled receptors (PAR-1
to -4) activated by the proteolytic removal of an inhibi-
tory amino terminus by cleavage at a site specific to each
receptor [8, 9]. Cleavage of the N-terminus exposes a new
N-terminal tethered ligand able to bind to another site on
the molecule and activate the receptor. Serine proteases of
the coagulation cascade are an important group of PAR
activators and, for example, thrombin is an activator of
PAR-1, PAR-3 and PAR-4, factor Xa (FXa) activates PAR-1
and PAR-2 and FVIIa activates PAR-2 [10]. Other impor-
tant activators of PAR-2 include mast cell tryptase, trypsin
and the serine proteases associated with house dust mite
allergens Der p3 and Der p9 [5, 11, 12]. Conversely,
neutrophil-derived proteases, neutrophil elastase, cathe-
psin G and proteinase 3 can inactivate PAR-1 and PAR-2,
disarming them by the cleavage of the N-terminal exodo-
main downstream from the activation site [13, 14].
PARs 1–4 are expressed by the normal bronchial epithe-
lium, with an apical distribution of PAR-1 and PAR-3 and a
more diffuse distribution of PAR-2 and PAR-4 [15, 16]. PARs
on the airway epithelium translate endogenous and exogen-
ous proteolytic activity in epithelial lining fluid into both
pro-inflammatory [5] and anti-inflammatory bronchopro-
tective signals [16, 17]. PAR-1- and PAR-2-activating pep-
tides have been shown previously to stimulate primary and
A549 bronchial epithelial cell lines to synthesize PGE2 [18].
Additionally, PGE2 stimulates the repair response of me-
chanically wounded 16HBE 14o bronchial epithelial cells
in culture [19]. In particular, the PAR-2-PGE2-prostanoid EP
receptor axis has been proposed to have anti-inflammatory
and bronchoprotective effects in the airway [20].
We, therefore, tested the hypothesis that activation of
PAR-1 and PAR-2 expressed by the 16HBE 14o bronchial
epithelial cell line stimulates epithelial repair via effects
on fibrin formation.
In summary, we investigated the effect of a PAR-1
agonist peptide, TFRIFD-NH2 and control partially
scrambled peptide FTRIFD-NH2, and a PAR-2 agonist
peptide, SLIGKVD-NH2 and control partially scrambled
LSIGKVD-NH2, on fibrin formation and the repair of
wounded 16HBE 14o epithelial cell layers in culture. We
investigated the expression of PAR-1 and PAR-2 in this
model, the effect of PAR-neutralizing antibodies and the
effect of the exogenously added proteases, FXa and neu-
trophil elastase. Additionally, we investigated the expres-
sion of PGE2 receptors (EP-1 to EP-4) and the influence of
PGE2 and indomethacin on the repair response.
Methods
Culture of 16HBE 14o cells
16HBE 14o cells were cultured for 48h in 24-well plates
as described previously [7] until fully confluent. At con-
fluence, cells were washed with PBS and quiesced over-
night in serum-free MEM-ITS [basal MEM containing 2mM
L-glutamine and antibiotic/antimycotic (100U/mL penicil-
lin G, 100mg/mL streptomycin, 250 ng/mL amphotericin B
(antibiotic–antimycotic liquid supplement (100) (Invitro-
gen Ltd, Paisley, Renfrewshire, UK)] supplemented with 10
mg/mL bovine insulin, 5.5mg/mL human transferrin and
5ng/mL sodium selenite [ITS liquid media supplement
(100) (Sigma, Dorset, UK)]. Before each experiment, cells
were washed by adding 500mL per well of phosphate-
buffered saline (PBS, Invitrogen Ltd), and 250mL of fresh,
serum-free MEM-ITS was added to each well.
Stimulation of 16HBE 14o cells with protease-activated
receptor peptide agonists
We used synthetic activating peptides at a concentration
shown previously to induce the release of cytokines and
PGE2 in primary and human bronchial epithelial cell lines
[18]. Synthetic PAR-1 peptide agonist (TFRIFD-amide), PAR-
2 peptide agonist (SLIGKVD-amide) and the corresponding
PAR-1 control peptide with the first two amino acids in
reverse order (FTRIFD-amide) and PAR-2 control peptide
(LSIGKVD-amide), were prepared as a 10mM stock solution
in 1% DMSO and added to cells in a final concentration of
400mM in a volume of 250mL per well and the plate was
incubated for 30min at 37 1C. Peptides were synthesized by
Peptide Protein Research Ltd (Hampshire, UK). A final
concentration of 0.04% DMSO was also included as a
control. Wound repair was carried out as described below.
The effect of protease-activated receptor neutralizing
antibodies
16HBE 14o cell layers were treated with PAR-1- (mouse
monoclonal ATAP2) and PAR-2 (mouse monoclonal SAM11)-
neutralizing antibodies (Santa Cruz Biotechnology, supplied
by Insight Biotechnology Ltd,Wembley, UK) or normalmouse
IgG (Sigma) at 20mg/mL for 60min before wounding.
Kinetic analysis of wound repair of 16HBE 14o cells in the
presence of protease-activated receptor-activating peptides
Cells were mechanically wounded with a P2 Gilson pipette
tip, one horizontal scrape per well. Immediately after
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wounding, the plate was placed on the heated stage at
37 1C of the inverted wide field kinetic video microscope
(Zeiss Axiovert 200m; Carl Zeiss Ltd, Hertfordshire, UK)
and Volocitys software was used to take images of the
same section of wound for 13 h, with time intervals of
15min. Volocitys software was also used to analyse
wound repair by taking 10 measurements across the
wound at each time-point up to 13 h.
Effect of protease-activated receptor-activating and
control peptides on fibrinogen, factor XIIIA and D-dimer
expression following wounding
Synthetic PAR-1 and PAR-2 peptide agonists and control
peptides were added to cells at a final concentration of
400mM, in a volume of 250 mL per well and the plate was
incubated for 30min at 37 1C. For cells that were exposed
to a PAR peptide agonist in the presence of indomethacin,
cells were pre-treated with indomethacin at a final con-
centration of 10mM for 30min at 37 1C before the addition
of the PAR peptide agonist. Cells were mechanically
wounded with a P2 Gilson pipette tip in a cross-hatch
pattern of 2, 4 or 8 scrapes (W2, W4 and W8) and
incubated at 37 1C for 2 h. Supernatants were harvested,
cleared by centrifugation and stored in aliquots at 80 1C
before analysis of fibrinogen, FXIIIA and for D-dimers by
immunoblot, as described previously [7]. In view of the
wide tissue distribution of tissue transglutaminase, it has
been confirmed that the FXIIIA antibodies used in this
study do not cross-react with purified tissue transglutami-
nase as determined by a direct ELISA (Hugh Hoogendoorn,
President, Affinity Biologicals, personal communication).
Immunohistochemical analysis of protease-activated
receptor-1 and protease-activated receptor-2 expression
16HBE 14o cells were grown to confluence and where
indicated NE was added at 0.3 U/mL (200 nM) for 30min.
Cells were wounded and either fixed immediately or
incubated for further 2 h. Cells were fixed in 4%w/v
paraformaldehyde in PBS for 30min, washed in PBS and
permeabilized with ice-cold methanol for 5min at20 1C.
Cells were washed in PBS and incubated overnight in PBS
containing 1%w/v bovine serum albumin at 4 1C to block
non-specific binding sites. Cells were incubated with
primary PAR-1 and PAR-2 antibody (Santa Cruz Biotech-
nology, as above) at 1 mg/mL in PBS containing 1% BSA
for 1 h at room temperature, washed five times for 5min
each with PBS containing 0.02% Tween-20, and the
secondary antibody, goat anti-mouse Alexa Fluor 488
F(ab’)2 fragment (Invitrogen Ltd) added at 1.5 mg/mL for
1 h at room temp and the washing steps repeated. The
slides were mounted using a Vectashield mounting med-
ium (Vector Labs, Peterborough, UK) and viewed using a
Zeiss LSM 510 confocal microscope.
Receptor mRNA expression
Total RNA isolation for reverse transcriptase-polymerase
chain reaction (RT-PCR). 16HBE 14o cells were seeded
at a density of 400 000 cells per well in six-well plates and
cultured for 48 h until fully confluent. At confluence, cells
were quiesced overnight. Before the experiment, MEM-
ITS was refreshed. Cells were maximally wounded with
four horizontal scrapes and four vertical scrapes and
subsequently incubated for 2, 4, 6, 8 and 10 h at 37 1C.
Cells were washed and harvested by trypsinization and
centrifugation. To each tube, 600 mL of pre-chilled dena-
turing solution (Promega, Southampton, UK) was added
and the mixture homogenized (Ultra-Turrax T25, Janke &
Kunkel IKA Labortechnik, Staufen, Germany) at
24 000 r.p.m for 1min at room temperature. Total RNA
was extracted from the homogenate with phenol : chlor-
oform : isoamyl alcohol (99 : 24 : 1, pH 4.7) (Promega) and
precipitated from the upper phase with an equal volume of
isopropanol at 20 1C for 30min. The RNA was recovered
by centrifugation at 10 000 g for 20min at 4 1C, washed
with ice-cold 75%v/v ethanol and air dried in an RNase-
free environment for 15min. RNA was dissolved in nucle-
ase-free water and RNA concentration and purity were
estimated by optical density determination. The 260/280
ratio was usually41.6, indicating suitable purity of RNA.
Primer design. The ‘Blast’ tool was used to design a
forward and reverse primer pair (Table 1) against a region
of the gene in question.
One-step reverse transcriptase-polymerase chain reaction
for protease-activated receptor-1, PAR-2 and b-actin. A
single host mix of 50 mL was created, consisting of 25 mL
of two-times concentrated reaction mix (Invitrogen), 1 mL
Table 1. Forward and reverse primer sequences used for RT-PCR
Gene Direction Sequence
Product
size (bp) Tm ( 1C)
b-actin Forward gcgggaaatcgtgcgtgacatt 232 57.0
Reverse gatggagttgaaggtagtttcgtg 56.0
PAR-1 Forward ggatatttgaccagctcctgg 400 54.0
Reverse agatggccagacaagtgaagg 54.0
PAR-2 Forward ctgcatctgtcctcactggaa 400 54.0
Reverse attgccagggagatgccaatg 54.0
EP-1 Forward gcgctgcccatcttctccatga 448 59.0
Reverse tgccccgggtactgcagctcata 59.0
EP-2 Forward tctccttgttccacgtgctg 446 54.0
Reverse gagcaccgagacaatgagaa 52.0
EP-3 Forward atgaaggagacccggggctacgga 515 63.0
Reverse cgcgtcttcatgtggctcgcatac 61.0
EP-4 Forward gcgagtacagcaccttcatt 543 52.0
Reverse agatgaccatctggatctcg 52.0
PAR, protease-activated receptor; RT-PCR, reverse transcriptase poly-
merase chain reaction.
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of forward (0.1 mg/mL) and 1 mL of reverse (0.1 mg/mL)
primers for PAR-1 and PAR-2 (Sigma-Genosys Ltd, Cam-
bridge, UK), 1 mL of SuperScriptTM II RT/platinums Taq Hi
Fi Mix, 1 mL of template RNA (1 mg) and 21 mL of nuclease-
free water. RT-PCR reactions were subjected to 50 1C for
30min to synthesize the cDNA, then pre-denaturation for
2min at 94 1C, followed by 40 cycles of amplification
(PAR-1 and PAR-2) or 30 cycles of amplification (b-actin)
consisting of denaturation at 94 1C for 15 s, annealing at
60 1C for 20 s and extension for 45 s at 68 1C. This was
followed by a final extension step of 10min at 72 1C.
Under these conditions, the amplification of each
product and the internal standard was linear.
One-step reverse transcriptase-polymerase chain reaction
for EP-1–4. A single host mix of 50 mL was created,
consisting of 25 mL of two-times concentrated reaction
mix (Invitrogen), 1 mL of forward (0.1 mg/mL) and 1 mL of
reverse (0.1 mg/mL) primers for EP-1 (Sigma-Genosys Ltd),
1 mL of SuperScriptTM II RT/platinums Taq Hi Fi Mix, 1 mL
of template RNA and 21 mL of nuclease-free water. RT-PCR
reactions were subjected to 50 1C for 30min to synthesize
the cDNA, then pre-denaturation for 2min at 94 1C,
followed by 40 cycles of amplification consisting of
denaturation at 94 1C for 15 s, annealing at 64 1C for EP-
1, 56 1C for EP-2, 66 1C for EP-3 and 57 1C for EP-4, for
20 s and extension for 45 s at 68 1C. This was followed by a
final extension step of 10min at 72 1C.
Under these conditions, the amplification of each
product was linear.
Analysis of reverse-transcriptase polymerase chain reaction
products by agarose gel electrophoresis. Products were ana-
lysed on a 2% (w/v) agarose (BDH) gel containing 0.0001%
v/v ethidium bromide alongside a 100bp DNA marker
ladder (Invitrogen). Bands were visualized by ethidium
bromide fluorescence under ultraviolet light. Densitometry
was carried out using SynGene software, to semi-quantify
the relative abundance of mRNA bands encoding each gene
sequence compared with the internal control, b-actin.
Quantitative real-time reverse-transcriptase polymerase
chain reaction. Quantitative reverse transcriptase-poly-
merase chain reaction (qRT-PCR) was used to confirm the
absence or presence of changes in the expression of PAR-
1, PAR-2, EP-2 and EP-3 receptors. Cells were cultured as
described above, and the receptor expression was deter-
mined in the absence and presence of PAR-1- and PAR-2-
activating peptides (400 mM) added for 30min before
wounding the cells mechanically, as described above.
RNA was isolated at 6- and 20-h post-wounding using
the RN-easy (Qiagen, Crawley, UK) and cDNA made using
the Superscript III platinum kit (Invitrogen). The samples
were analysed using a 7900HT TaqMan real-time PCR
system (Applied Biosystems, Warrington, UK).
Sequences of the primers used for qRT-PCR (Applied
Biosystems)
PAR-1 Forward: cggtttctggctgtggtgta
PAR-2 Forward: ctccaggaagaaggcaaacattg
EP-2 Forward: gggcacccctacttctacca
EP-3 Forward: gggctctcctcgttgttcat
PAR-1 Reverse: aaggaagcccttcccagagta
PAR-2 Reverse: gggatggtgaccagcagaat
EP-2 Reverse: agcagaagagcagggagact
EP-3 Reverse: tgcggcgccctgat
Immunoassay for interleukin-8. 16HBE 14o cells were
seeded at a density of 400 000 cells per well in 6-well
plates and cultured for 48 h until fully confluent. At
confluence, cells were quiesced overnight in serum-free
MEM-ITS. Cell layers were maximally wounded with four
horizontal scrapes and four vertical scrapes and incubated
for 12 h at 37 1C. The supernatants were harvested, cleared
by centrifugation and stored at 80 1C. IL-8 was analysed
using a Pelikine CompactTM human IL-8 ELISA kit (Mast
Diagnostics, Liverpool, UK) as described by the manufac-
turers. IL-8 in cell culture supernatants diluted 1 in 10
with MEM-ITS was assayed against a standard IL-8 con-
centration curve prepared in the range of 1, 2.5, 6.1, 15.4,
38.4, 96 and 240 pg/mL.
Immunoassay for prostaglandin E2 metabolites. The pros-
taglandin E metabolite kit (Cayman Chemical Co., Ann
Arbor, MI, USA) was used according to the manufacturer’s
instructions to measure metabolites of PGE2 in culture
supernatants from wounded cell layers in the absence and
presence of PAR-1 and PAR-2 peptides.
Effect of indomethacin on the repair of 16HBE 14o
monolayers. A concentration range of 0, 0.01, 0.1, 1, 3
and 10 mM indomethacin (1mM stock dissolved in 1%
DMSO: Sigma) was added to cells in a volume of 250 mL
per well and the plate was incubated for 30min at 37 1C. A
concentration range of up to 0.01% DMSO, corresponding
to 10 mM indomethacin was also included as the vehicle
control. Analysis of wound repair was then carried out as
described below.
Effect of prostaglandin E2 on repair of 16HBE 14o
monolayers. A concentration range of 0, 0.1, 1, 5, 10 and
20 mg/mL PGE2 (2mg/mL stock dissolved in 50% ethanol/
50% MEM-ITS: Sigma) was added to cells in a volume of
250 mL per well and the plate was incubated for 30min at
37 1C. Ethanol controls at a final concentration of
0.0025%, 0.025%, 0.125%, 0.25% and 0.5% correspond-
ing to 0.1, 1, 5, 10 and 20 mg/mL PGE2, respectively, were
also included. Analysis of wound repair was then carried
out as described below.
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Stimulation of 16HBE 14o cells with exogenous factor
Xa. A concentration range of: 0, 50, 100 and 200 nM FXa
(20mM stock dissolved in PBS: Calbiochems, supplied by
Merck Chemicals Ltd., Nottingham, UK) was added to cells
in a volume of 250 mL per well and the plate was incubated
for 30min at 37 1C. Analysis of wound repair was then
carried out as described below.
Effect of neutrophil elastase on the repair of 16HBE 14o
monolayers. A concentration range of 0, 0.1, 0.03, 0.1, 0.3
and 0.5 U/mL neutrophil elastase (3 U/mL stock dissolved
in 1 PBS: Sigma) was added to cells in a volume of 250 m
L per well and the plate was incubated for 30min at 37 1C.
Analysis of wound repair was then carried out as de-
scribed below.
Wound repair of 16HBE 14o cells in the presence of
factor Xa, neutrophil elastase, indomethacin and prosta-
glandin E2. Cells were mechanically wounded with a P2
Gilson pipette tip, one horizontal scrape per well. Imme-
diately after wounding, one photograph per well was
taken of a representative section of wound using the
inverted microscope (Leica Microsystems, Wetzlar, Ger-
many) and a Ricoh XR-3000 35mm camera. Cells were
returned to the incubator, at 37 1C for 13 h. A second set of
photographs was then taken of the same section of wound.
Photographs were developed and wound repair was ana-
lysed by taking 10 measurements across the wound and
the % original wound width was calculated at 13 h.
Supernatants and cells were harvested and stored at
80 1C, as described above.
Stimulation of 16HBE 14o cells with neutrophil elasta-
se. A concentration range of 0, 0.1, 0.03, 0.1, 0.3 and 0.5U/
mL neutrophil elastase (3U/mL stock dissolved in PBS:
Sigma) was added to cells in a volume of 250mL per well
and the plate was incubated for 30min at 37 1C. Cells were
then mechanically wounded (W8) as described above and
incubated for 20min and 2h at 37 1C. Cell culture super-
natants were then harvested at each time-point, as described
above, and the concentration of fibrinogen and FXIII was
determined by immunoblot as described previously [7].
Lactate dehydrogenase (LDH) assay. The LDH assay (TOX-
7, Sigma) was used to determine whether the effects of
neutrophil elastase on wound repair and coagulation
factors release were due to cytotoxicity. The assay was
adapted for use in a 96-well plate. Cell culture super-
natants and cell lysates were diluted 1 in 10 by adding 5 m
L of sample to 45 mL of PBS. The LDH assay solution was
prepared by mixing equal volumes of LDH substrate, LDH
enzyme and LDH tetrazolium dye. To each well, 25 mL of
the LDH assay mixture was added. The plate was incu-
bated for 5min at room temperature, protected from light.
In order to stop the reaction, 8.33 mL of 1 M HCl was added
to each well and the absorbance at 490 nm was measured
using a microplate reader (Dynex MRX microplate reader,
West Sussex, UK).
Statistical analysis
Statistical analysis was carried out using the GraphPad
Prism 4 software. The effect of wounding on receptor
expression and coagulation factor concentration in cul-
ture supernatants was analysed by one-way ANOVA and
Dunnett’s post hoc test. Data on the effect of peptides
under each condition were analysed by two-way ANOVA
and Bonferroni post hoc tests.
Results
The effect of protease-activated receptor-1- and protease-
activated receptor-2-activating peptides on wound repair
Using video kinetic analysis, initial experiments found no
effect of PAR-1- and PAR-2-activating peptides added at a
final concentration of 100 mM on wound repair. However,
the data in Fig. 1 show that both PAR-1- and PAR-2-
activating peptides added at a final concentration of 400mM
significantly increase the rate of repair of bronchial
epithelial cell monolayers, compared with the untreated
wells and wells treated with control peptides. With respect
to the untreated cell cultures, the mean wound width at 13 h
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Fig. 1. Effect of a PAR-1 (a) and a PAR-2 (b) peptide agonist on the rate of
wound repair of 16HBE 14o cell layers. CP denotes control peptide. Data
represent meanSEM of three independent experiments. Po0.05,
Po0.01 and Po0.001 compared with no drug control.
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was 263.5814.82mm compared with 768.2819.89mm at
0 h, indicating 34.3% of the original wound width remained
open. The PAR-1 and PAR-2 control peptides had no effect
on wound repair compared with the no drug control wells.
However, both PAR-1 and PAR-2 peptide agonists signifi-
cantly enhanced wound repair. Wound repair was complete
12 h following the addition of the PAR-1 peptide agonist,
and 11h following the addition of the PAR-2 peptide
agonist. The effect of the PAR-2 agonist was significantly
(Po0.05) greater than that of PAR-1 agonist between the
time-points of 3-h and 10-h post-wounding.
Conversely, in separate experiments, antibodies against
amino acids 42–55 of human PAR-1 (ATAP2) and amino
acids 37–50 of human PAR-2 (SAM11) significantly in-
hibited the repair response. The PAR-1 antibody reduced
the initial rate of wound repair from 130.65.87 to
92.416.3 mm/h (P= 0.03, n= 3), and wound closure from
98.31.25% to a maximum of 65.14.7% at 10-h post-
wounding (Po0.0001, n= 3). Similarly, the PAR-2 anti-
body reduced the initial rate of wound repair from
130.65.87 to 96.79.5 mm/h (P= 0.01, n= 5), and wound
closure from 98.321.25% to 73.67.1% (Po0.0001,
n= 3). In the presence of either of the antibodies, the
wounds remained open even after prolonged overnight
incubation. Normal mouse IgG had no significant effect
on any parameter.
Protease-activated receptor-1 and protease-activated
receptor-2 expression in response to wounding
PAR-1 and PAR-2 were both constitutively expressed by
16 HBE cells, as reported previously [21]. Semi-quantita-
tive RT-PCR indicated that their expression was not
increased with wounding at any time-point (fig. 2), and
this was confirmed by quantitative real-time RT-PCR.
qRT-PCR analysis also demonstrated that the presence of
PAR-activating peptides in the cultures did not increase
PAR1 or PAR-2 expression.
Immunohistochemical analysis demonstrated the con-
stitutive expression of both PAR-1 and PAR-2 receptors at
the protein level (supporting information Figs S1 and S2).
PARs were distributed throughout the cytoplasm and on
the cell membrane. In the wounded cultures, we observed
a tendency to increased fluorescence in the cells at the
wound edge, although this was not consistently seen
between cultures or even along the length of a single
wound, and was not quantifiable. There was also no clear
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Fig. 2. (a). Representative gel illustrating the effect of time post-wound-
ing on the mRNA expression of PAR-1 in 16HBE 14o cells. 2% (w/v)
agarose gel electrophoretic separation of PAR-1 amplicons generated by
RT-PCR from the total RNA extracted from 16HBE 14o cells at various
time-points following mechanical wounding. Lane contents as follows:
BP, 100 bp ladder; BL, baseline (unwounded cells); 2 h, 2-h post-wound;
4 h, 4-h post-wound; 6 h, 6-h post-wound; 8 h, 8-h post-wound; 10 h,
10-h post-wound. (b) Effect of wounding on mRNA levels of PAR-1 in
16HBE 14o cells. Data bars indicate the ratio of PAR-1 to b-actin
internal control. BL, baseline i.e. unwounded cells. Data represent mean
SEM of three independent experiments. (c) Representative gel illustrating
the effect of time post-wounding on the mRNA expression of PAR-2 in
16HBE 14o cells. 2%w/v agarose gel electrophoretic separation of PAR-
2 amplicons generated by RT-PCR from the total RNA extracted from
16HBE 14o cells at various time-points following mechanical wound-
ing. Lane contents as follows: BP, 100 bp ladder; C, negative control (no
RNA); BL, baseline (unwounded cells); 2 h, 2-h post-wound; 4 h, 4-h
post-wound; 6 h, 6-h post-wound; 8 h, 8-h post-wound; 10 h, 10-h post-
wound; Pl, Platelet RNA (positive control). (d) Effect of wounding on
mRNA levels of PAR-2 in 16HBE 14o cells. Data bars indicate the ratio
of PAR-2 to b-actin internal control. BL, baseline i.e. unwounded cells.
Data represent meanSEM of three independent experiments.
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evidence of receptor redistribution to the cell membrane
following wounding.
The effect of protease-activated receptors on coagulation
factor release
In view of the role of fibrin formation in wound repair [7],
we investigated the effects of PAR activation on the
release of the coagulation factors fibrinogen and FXIIIA
into cell culture supernatants. If the increased rate of
wound repair in response to PAR-1 and PAR-2 agonists
was occurring via enhanced fibrin formation, it was
expected that the concentration of D-dimer fragments in
cell culture supernatants would be increased. PGE2 has
also been to shown to be a product of PAR-activated
bronchial epithelial cells [18] and to stimulate bronchial
epithelial wound repair [19]. Cells were therefore pre-
treated with the non-specific COX inhibitor indomethacin,
in order to determine whether the effect of PAR-1 and
PAR-2 agonists on the coagulation factor release was
mediated via prostanoid production.
Figure 3 illustrates the effect of wounding, and the
effect of PAR-1 and PAR-2 peptides on confluent and
wounded cultures, in the absence and presence of indo-
methacin, on the release of fibrinogen (Fig. 3a), FXIII (Fig.
3b) and the formation of D-dimers as a marker of
fibrinogenesis and fibrinolysis (Fig. 3c).
As reported previously [7], mechanical wounding of
confluent 16HBE monolayers significantly (see Table 2)
increased the concentration of fibrinogen, FXIII and D-
dimers in the culture supernatant. Pre-treatment of the
monolayers with indomethacin before wounding had no
significant effect on levels of any coagulation factor,
indicating that prostanoids were not involved in the
response. However, the PAR-1 and PAR-2 peptide agonists
had strong stimulatory effects on the release of fibrinogen
and FXIII, and D-dimer formation, in both confluent and
wounded cell cultures. In the confluent monolayers, the
magnitude of the response to the PAR-2 peptide agonist
was greater than that for the PAR-1 agonist, significantly
so for both fibrinogen and D-dimer levels. The control
peptides, which had the first two amino acids in reverse
order, did not significantly enhance coagulation factor
levels in the supernatants, indicating that the agonist
peptides were activating the appropriate receptors. Con-
versely, the presence of the control peptides partially, but
significantly inhibited the increase in levels of coagula-
tion factors in culture supernatants in response to wound-
ing (Table 2). Indomethacin had no effect on the
coagulation factor levels stimulated by the PAR-1 agonist
in either confluent or wounded cell layers. However, a
significant inhibitory effect of indomethacin on the PAR-
2 stimulated increase in FXIII was observed (Fig. 3b) in
wounded cell cultures only, which translated into reduced
D-dimer levels in the same culture supernatants (Fig. 3c).
The effect of prostaglandin E2 and indomethacin on wound
repair and the release of coagulation factors
In view of reports that PGE2 enhances bronchial epithelial
repair [19] and PAR agonists stimulate human bronchial
epithelial cells to produce PGE2 [18], we investigated the
effect of exogenously added PGE2 on wound repair. Under
the conditions used, PGE2 in the concentration range
0.1–20 mg/mL did not stimulate repair of wounded
16HBE cell monolayers over 13 h (n= 3, data not shown).
In addition, indomethacin in the concentration range
0.01–10 mM had no effect over 13 h, indicating no role for
endogenous PGE2, or other prostanoids, in the repair
response (n= 3, data not shown).
Similarly, PGE2 in the concentration range of 1–20 mg/
mL did not significantly affect the fibrinogen, FXIIIA or
D-dimer concentration in confluent or wounded cell
cultures (n= 3, data not shown).
Expression of prostaglandin receptors in response to
wounding
Considering previous reports, the lack of effect of exogen-
ous PGE2 was somewhat surprising; hence, we examined
prostaglandin receptor expression under our serum-free
culture conditions. We detected no expression of EP-1 or
EP-4 receptors, which are the receptors reported to be
involved in bronchial epithelial repair [19]. The primers
for EP-1 and EP-4 were validated using a bladder smooth
muscle and dorsal root ganglion RNA control, respec-
tively, which showed the expression of each of the
receptors. However, EP-2 and EP-3 receptors were readily
detected (Fig. 4). EP-3 receptor expression increased
significantly with time post-wounding when compared
with the internal standard (Figs 4c and d), although this
was not observed for EP-2 receptors (Figs 4a and b). A
significant eight-fold increase in EP-3 receptor expression
in wounded cells was confirmed by qRT-PCR analysis of
cells following wounding and overnight incubation. There
was no significant increase in EP-3 mRNA expression at
the 6-h time-point, and no effect of wounding on EP-2
receptor expression at either time-point.
The effect of exogenously added factor Xa on wound
repair
As fibrin formation mediated by extrinsic coagulation
cascade proteases and protease-activated receptors appear
to be involved in the epithelial repair response, we tested
the effect of the exogenously added FXa on wound repair
in a range of concentrations including those normally
present in plasma. FXa significantly enhanced wound
repair at all concentrations tested in a dose-dependent
manner (Fig. 5).
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Fig. 3. Effect of mechanical wounding, PAR-1 and PAR-2 peptide agonists and indomethacin on the concentration of (a) fibrinogen, (b) FXIII, (c) D-
dimers in cell culture supernatants of 16HBE 14o cells 2 h postwounding confluent monolayers. C, confluent; W2, two wounds; W4, four wounds and
W8, eight wounds. Data represent meanSEM of three independent experiments. Po0.05, Po0.01, Po0.001 compared with the no drug
control.
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The effect of wounding on interleukin-8 release in culture
supernatants
As normal repair responses appear to be mediated via
protease-activated receptors that in wounded cell cultures
are activated by coagulation cascade proteases, and PAR
activation is linked with inflammatory responses, we
investigated the levels of the neutrophil chemoattractant
IL-8 in supernatants from unwounded and wounded
monolayer cultures 12-h post-wounding. IL-8 concentra-
tions were 449186 pg/mL in supernatants from un-
wounded monolayers and 1451120 pg/mL, which is
significantly (Po0.05) higher in supernatants from
wounded cultures (n= 5).
The effect of the neutrophil elastase on wound repair and
coagulation factors
Neutrophil elastase has been reported to both activate [22]
and disarm [13, 14] PARs, and to degrade coagulation
factors including FVII [23], FX [24] and FXIIIA [25].
Therefore, it was of interest to investigate the effect of
Table 2. The effect of scrambled control PAR-1 and PAR-2 peptide
agonists on the release of fibrinogen and factor XIII, and the formation
of D-dimers, 2 h after wounding (W) confluent (C) monolayers of 16 HBE
cell monolayers
Coagulation
factor
Condi-
tion No drug
Control peptide
PAR-1 (FTRIFD) PAR-2 (LSIGKVD)
Fibrinogen
(mg/mL)
C 0.670.44 0.220.01 0.760.64
W2 3.182.29 0.910.03 2.220.24
W4 8.411.39w 3.550.21ww 4.330.32ww
W8 21.231.33ww 5.320.48ww 6.150.31www
Factor XIII
(ng/mL)
C 4.491.96 2.180.08 2.920.25
W2 17.001.52 7.300.22ww 7.921.26ww
W4 22.302.40w 10.030.75ww 15.230.65ww
W8 24.435.40ww12.930.42ww 18.390.59www
D-dimers
(ng/mL)
C 2.330.27 4.191.32 2.940.60
W2 6.540.72 6.461.17 3.620.84
W4 10.422.03ww 8.340.95 7.360.84w
W8 16.211.10ww10.890.75w 9.201.34www
The degree of wounding is indicated as W2 (two wounds), W4 (four
wounds) and W8 (eight wounds). The effect of wounding on coagulation
factor concentration in culture supernatants was analysed by one-way
ANOVA and Dunnett’s post hoc test.
wPo0.05, wwPo0.01 and wwwPo0.001. Data on the effect of peptides under
each condition were analysed by two-way ANOVA and Bonferroni post hoc
tests. Significant differences between the peptide-treated and no drug
controls are indicated with asterisks; Po0.05, Po0.01 and
Po0.001. 0
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Fig. 4. (a) Representative gel demonstrating the effect of time post-
wounding on the mRNA expression of EP-2 in 16BHE 14o cells. 2%w/v
agarose gel electrophoretic separation of EP-2 amplicons generated by
RT-PCR from the total RNA extracted from 16HBE 14o cells at various
time-points following mechanical wounding. Lane contents as follows:
BP, 100 bp ladder; C, negative control (no RNA); BL, baseline (un-
wounded cells); 2 h; 2-h post-wound; 4 h, 4-h post-wound; 6 h, 6-h
post-wound; 8 h, 8-h post-wound 10 h, 10-h post-wound. (b) Effect of
wounding on the mRNA levels of EP-2 in 16HBE 14o cells. Data bars
indicate the ratio of EP-2 to b-actin internal control. BL, baseline i.e.
unwounded cell monolayers. Data represent meanSEM of three inde-
pendent experiments. (c) Representative gel demonstrating the effect of
time post-wounding on the mRNA expression of EP-3 receptor in 16HBE
14o cells. 2% (w/v) agarose gel electrophoretic separation of EP-3
amplicons generated by RT-PCR from the total RNA extracted from
16HBE 14o cells at various time-points following mechanical wound-
ing. Lane contents as follows: BP, 100 bp ladder; BL, baseline (un-
wounded cells; 2 h, 2-h post-wound; 4 h, 4-h post-wound; 6 h, 6-h
post-wound; 8 h, 8-h post-wound; 10 h, 10-h post-wound. (d) Effect of
wounding on the mRNA levels of EP-3 in 16HBE 14o cells. Data bars
indicate the ratio of EP-3 to b-actin internal control. BL, baseline i.e.
unwounded cell monolayers. Data represent meanSEM of four inde-
pendent experiments. Po0.05 compared with BL.
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this enzyme on epithelial repair. Neutrophil elastase sig-
nificantly inhibited epithelial repair in a dose-dependent
fashion in the concentration range of 0.01–0.5 U/mL (Fig.
6), indicating that neutrophil elastase did not activate
PARs. In addition, immunohistochemical analysis indi-
cated that neutrophil elastase (0.3 U/mL) did not cleave the
N-terminal domains recognized by the antibodies, and
therefore did not disarm either PAR-1 or PAR-2 (support-
ing information Figs S1 and S2).
The effect of neutrophil elastase on fibrinogen and
FXIII levels in culture supernatants was investigated by
immunoblot analysis. Neutrophil elastase reduced the
levels of both fibrinogen and FXIII in culture supernatants
harvested 2-h post-wounding in a concentration-depen-
dent manner (Fig. 7). The significant increase in fibrino-
gen (Fig. 7a) and FXIII (Fig. 7b) seen following wounding
in the absence of neutrophil elastase was significantly
reduced in the presence of 0.1–0.5 U/mL neutrophil elas-
tase, so that at 0.5 U/mL (0.34 mM), there was no longer any
significant difference in the concentrations of coagulation
factors between wounded and unwounded control cul-
tures. Levels of coagulation factors in supernatants har-
vested 20min after wounding were still significantly
higher than the control unwounded cultures (not shown).
The effect of neutrophil elastase was therefore both time
and concentration dependent.
Elastase in the concentration range of 0.01–0.5U/mL had
no effect on the distribution of LDH between the supernatants
and cell lysates indicating that the inhibition of wound repair
was not due to cytotoxicity induced by this enzyme.
Discussion
In addition to their role in fibrin formation, the role of the
coagulation cascade proteases in lung inflammation,
tissue remodelling and fibrosis in the airways has recently
been reviewed [10, 12, 26]. Important roles for PAR-1
expressed on pulmonary fibroblasts in the development of
fibrosis have been described, while the activation of
epithelial PAR-2 results in both pro-inflammatory [12]
and anti-inflammatory and cytoprotective effects [20]. We
now report that PAR-1 and PAR-2 peptide agonists
stimulate the rate of repair of mechanically wounded
bronchial epithelial cell monolayers in culture and en-
hance the formation of a fibrin provisional matrix to
support the repair process. Conversely, PAR-1- and PAR-
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2-neutralizing antibodies inhibited the repair response.
This indicates a role for endogenous proteases in the
normal repair process, conceivably membrane-bound
coagulation cascade proteases that we reported to be
involved in epithelial repair [7], or soluble proteases
released in response to wounding, such as MMP-1 or
human airway trypsin (HAT) that also activate PAR-1 and
PAR-2, respectively [27, 28].
Important roles for FXa, signalling through PAR-1 and
PAR-2 receptors, in pro-inflammatory and pro-fibrotic
responses following tissue injury have been described
previously [26]. We demonstrated previously increased
tissue factor (TF) and FVII expression in 16HBE 14o cells
in response to wounding [7] and the activation of FXa in
our model by the TF/FVIIa complex was indicated. En-
hanced bronchial epithelial wound repair in response to
the exogenously added FXa supports this previously
unrecognized role for endogenous FXa. EGFR induces cell
proliferation and migration and plays an important role in
normal epithelial repair [29]. PAR-1 and PAR-2 transacti-
vate epidermal growth factor receptor (EGFR) either by an
activation of intracellular signalling pathways leading to
src-dependent EGFR phosphorylation and/or the PAR-
induced release of EGFR ligands [reviewed in [12]]. Thus,
enhanced fibrin-dependent epithelial repair responses
induced via the coagulation cascade proteases may prove
to be mediated, indirectly, via EGFR activation.
The soluble peptides were chosen for their ability to act
as selective agonists at the PAR-1 (TFRIFD-NH2) and PAR-
2 (SLIGKVD-NH2) receptor [30, 31]. Reversal of the first
two amino acids in the amino terminal of the PAR-1- and
PAR-2-activating peptides SFLLRN and SLIGRL have
consistently been shown to yield a functionally inactive
peptide in many cells and tissues, and the FSLLRN and
LSIGRL peptides are often used as control peptides [11,
18]. We therefore reversed the order of the first two amino
acids in TFRIFD-NH2 and SLIGKVD-NH2 to provide con-
trol peptides. These control peptides had no stimulatory
effect on wound closure by 16HBE cells (Fig. 1), or on the
levels of fibrinogen, FXIIIA or D-dimers in control or
wounded cultures (Table 2) indicating the specificity of
the chosen agonist peptides.
Unexpectedly, the control peptides, FTRIFD-NH2 and
LSIGKVD-NH2, significantly decreased fibrin formation in
wounded cell cultures. The inhibitory effect of the control
peptides was only partial and the release of fibrinogen and
FXIIIA, and the formation of fibrin was still significantly
increased in wounded cell cultures compared with conflu-
ent monolayers (Table 2). A major role for the S37L38
dipeptide sequence in PAR-2 activation by SLIGRL has
been reported [32] and a reversal of this sequence generates
a peptide that inhibits the ability of exogenously added
trypsin and the newly formed tethered ligand, but not the
soluble activating peptide, to activate PAR-2 [33]. Simi-
larly, an essential role for the initial dipeptide sequence and
particularly phenylalanine, which must be preceded by
another amino acid in the TFRIFD sequence, has been
indicated [34]. Modification of the human PAR-1 peptide
by the deletion of the first amino acid produced a thrombin
antagonist. The control peptides used in our study, with the
first two amino acids reversed, apparently acted as inhibi-
tors or antagonists of endogenous PAR-1- and PAR-2-
activating proteases involved in fibrin formation.
Importantly, the control peptides did not affect the rate
of epithelial repair (Fig. 1). We demonstrated previously
an essential role for tissue factor and proteases of the
coagulation cascade in fibrin formation and wound repair
[7]. We also reported that when tissue factor-mediated
activation of coagulation cascade proteases was inhibited,
fibrinogen continued to accumulate in the culture super-
natant of wounded cell monolayers [7]. Together with the
present findings, regarding the stimulatory effects of PAR
activation on fibrinogen and FXIIIA release and D-dimer
formation, our findings are indicative of an additional
effect of soluble proteases such as matrix metalloproteases
and human airway trypsin, released in response to
wounding and able to activate PAR-1 and PAR-2, respec-
tively. Further experiments are needed to investigate
whether the scrambled peptides limit PAR activation by
endogenous soluble and/or membrane-bound proteases in
our model, or act as PAR antagonists.
Immunohistochemical analysis revealed that PARs 1–4
are expressed in the normal bronchial epithelium, and RT-
PCR analysis of primary cells and epithelial cell lines in
culture has confirmed this [15, 16]. PAR expression is
upregulated by a number of different stimuli and a
modulation of receptor expression regulates PAR activity
[12]. PAR-1 and PAR-2 expression are up-regulated dur-
ing the development of respiratory diseases such as
pulmonary fibrosis, asthma and bronchitis, in which they
play a role in the development of disease pathology.
Notably, PAR-1 is strongly associated with the develop-
ment of tissue fibrosis [10] and PAR-2 with inflammatory
airways diseases [12]. The 16HBE 14o cell line has been
shown previously to express PAR-1 [21] and PAR-2 [21,
14], which we have confirmed in this study for cells
growing in serum-free conditions. It was reported pre-
viously that continued exposure to PAR-activating pep-
tides enhances PAR expression in A549 epithelial cells
[12]. We considered the possibility that the proposed
continued stimulation of PARs by endogenous coagulation
cascade proteases following wounding in our model may
relate to a small sub-population of cells at the wound edge
that did not lead to a detectable overall increase in PAR-1
or PAR-2 expression. However, there is little evidence for
an increased expression of PAR-1 and PAR-2 receptors
with wounding or on exposure to high concentrations of
PAR-activating peptides at the mRNA or protein level.
Initially, we were surprised to find no effect on the rate
of epithelial repair on the addition of PGE2 in the
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concentration range shown previously by Savla et al. [19]
to enhance the repair of mechanically wounded 16HBE
14o cell layers. In the study by Savla and colleagues
(2001), cells were grown in a medium containing 10%
fetal bovine serum, and the effect of PGE2 added in a
medium containing 10% fetal bovine serum was mediated
by EP-1 and EP-4 receptors. However, in our serum-free
conditions, EP-1 and EP-4 were not expressed, either at
baseline or following wounding, although the expression
of the EP-2 and EP-3 receptors was readily detected.
Subsequent experiments showed that EP-1 and EP-4 were
also not expressed at baseline or following wounding, in
the presence of serum (results not shown). Because the
primers for EP-1 and EP-4 were validated using a bladder
smooth muscle and dorsal root ganglion RNA control,
respectively, it appears that the 16HBE 14o cell line
expresses only EP-2 and EP-3 under our culture condi-
tions. Additionally, the study by Savla et al. [19], used the
non-specific receptor antagonists AH6809 and AH23848
to indicate the involvement of EP-1 and EP-4 receptors,
respectively, in epithelial repair. However, AH6809 is an
antagonist equally at EP1, EP2 and EP3 receptors, as well
as DP and TP receptors, and AH23848 is a more potent
antagonist of EP-3 than EP-4 receptors, and is also an
antagonist at DP and TP receptors [35]. Therefore, con-
sidering the selectivity and affinity of the EP receptor
agonists and antagonists used by Savla et al. [19], it is
possible that EP-2 or EP-3 receptors mediated epithelial
repair responses in that study.
We reported previously very low levels of PGE2 that did
not increase with wounding in our serum-free model of
bronchial epithelial repair [7]. Serum-free conditions are
known to limit PGE2 production [36, 37], and it was
therefore not surprising to observe no effect of indo-
methacin on the rate of wound repair or on coagulation
factor release in response to wounding alone. However, a
significant inhibitory effect of indomethacin on fibrin
formation, measured as D-dimer concentration, indicates
that PGE2 or other prostanoid was produced in response
to the additive effect of both a mechanical wound and the
PAR-2-activating peptide, but not in control unwounded
cell cultures. PAR-1- and PAR-2-activating peptides at
400 mM concentrations have been shown previously to
stimulate bronchial epithelial cell lines to synthesize
PGE2 [18], but at levels too low to stimulate repair [19],
and the effect of a PAR-2 agonist was greater than a PAR-
1activating peptide [18]. PAR-activating peptides have
relatively low potency and since the peptides are suscep-
tible to aminopeptidases, their degradation would be
enhanced in serum-free conditions. It has been suggested
previously that PGE2 is only produced at effective con-
centrations when PAR-2 is activated strongly, for example
by high concentrations of activating peptides that main-
tain its concentration in the cell environment and cause
sustained activation [13]. Thus, if the peptides were
present at suboptimal concentrations, a second, proteoly-
tic, PAR-2-activating stimulus from wounded cell layers,
such as FXa or human airway trypsin may generate
sufficient PGE2 to influence fibrin formation. However,
analysis of culture supernatants under all conditions of
wounding and in the presence the PAR-activating pep-
tides found only pg/mL levels of PGE2 and PGE2 metabo-
lites (data not shown). Also, as exogenously added PGE2,
alone, did not affect the rate of wound repair or coagula-
tion factor expression in wounded and unwounded cul-
tures, an effect of indomethacin on the synthesis of other
prostanoids, or other cyclooxygenase-independent effects
[38], is likely.
In evolutionary terms, the role of coagulation enzymes
is related to the formation of fibrin at wound sites and the
induction of an inflammatory response, which developed
as a rapid response system to detect and clear microbes
that have breached epithelial barriers, namely the exclu-
sion of invading pathogens by the innate immune system
[39, 40]. PARs play a crucial role in the cross-talk between
coagulation and inflammation [41, 26]. Activation of the
coagulation cascade not only leads to fibrin formation
but, also via PAR-1 and PAR-2 activation, the release of
pro-inflammatory mediators that stimulate tissue factor
expression, and the activity of the extrinsic coagulation
cascade leading to persistent fibrin formation [10]. PAR-1
and PAR-2 activation were reported previously to stimu-
late IL-8 release from A549, BEAS-2B and primary
bronchial epithelial cells, although PAR-2 agonist pep-
tides were more potent and more effective than PAR-1-
activating peptides [18]. Others, using the same peptide
agonists as those used in our study, showed that IL-8
release from 16HBE 14o cells was stimulated by PAR-2
but not PAR-1 agonists [21]. Post-transcriptional upregu-
lation of IL-8 release from A549 cells through PAR-2-
dependent transactivation of EGF receptors has also been
described recently [42]. As PGE2 exerts a positive tran-
scriptional regulation of IL-8 synthesis in a number of
cells including fibroblasts, T-cells, colonic and pulmonary
epithelial cells [43] and as our serum-free conditions limit
PGE2 synthesis, we investigated whether wounding alone
induced IL-8 synthesis under our assay conditions. The
increased synthesis and release of IL-8 in our wounded
cultures, in the absence of exogenously added PAR-
activating proteases or peptides, is indicative of either
PAR-1 and/or PAR-2 activation by endogenous proteases,
either coagulation cascade proteases or others released
from wounded cells.
IL-8 is a potent neutrophil chemoattractant and the
normal physiologic role of neutrophils recruited to wound
sites is to aid in the repair process by clearing foreign
particles and microbes, tissue debridement and wound
cleaning [44]. However, in various pathological condi-
tions neutrophil elastase is released from activated cells
into the extracellular matrix where it has a number of
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well-recognized roles in both tissue injury (matrix de-
struction) and repair (matrix accumulation) [45–47]. Stu-
dies have shown that elastase activates PAR-1 in human
lung epithelial cells to induce apoptosis [22] but disarms
PAR-2 in lung epithelial cells [13, 14]. These effects appear
to be specific for the epithelial cell type, as elastase
disarms PAR-1, but activates PAR-2, in non-epithelial
cells [13]. We found that neutrophil elastase significantly
inhibited epithelial repair, which may be the result of the
degradation of coagulation factors, as neutrophil elastase
did not apparently disarm PAR-2 receptors on epithelial
cells. FXIIIA cross-links and stabilizes fibrin and plays a
role in angiogenesis and tissue repair [48]. We demon-
strated previously an essential role for FXIIIA in epithelial
repair [7] and its degradation by neutrophil elastase has
been described previously [25]. Thus it seems likely that
degradation of FXIIIA, fibrinogen or even cross-linked
fibrin [49] by neutrophil elastase is at least partly respon-
sible for inhibition of epithelial repair.
The airway epithelium is central to the pathogenesis of
asthma [50]. An inherent fragility in the bronchial epithe-
lium resulting from defective tight junctions is a feature of
the asthmatic airway [27], which increases the risk of
asthma exacerbation due to environmental factors [51]. In
addition, a lower level of anti-protease expression in the
asthmatic airway epithelium compared with normal has
been suggested to render the airway epithelium in asth-
matics more susceptible to damage via allergens with
proteolytic activity [52]. Our findings may be relevant to
the airway epithelium in severe asthma, which is domi-
nated by a neutrophilic inflammatory response [53]. As
we have shown in this study, neutrophil elastase not only
damages the airway epithelium [46] but also inhibits the
repair response. Significant airway epithelial damage is
associated with plasma exudation [54] and since tissue
factor-bearing cells are believed to be involved only in the
initiation of clot formation, the growth of the clot is
dependent on the propagation of coagulation to bulk
plasma [55]. Thus, while plasma exudation is normally
considered a defensive repair response, plasma exudation
may become a pathophysiological event supporting ex-
cessive fibrin formation in severe asthma [56, 57], as we
demonstrated recently [58], as well as acute inflammatory
and chronic interstitial lung diseases [59].
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Figure S1. Immunostaining of PAR-1 in 16HBE 14o
cell layers. a; no primary antibody negative control. LHS –
fluorescent image, RHS – DIC image, b; confluent cell
layer, c; cell layer 2 h post wounding, d; cell layer treated
with neutrophil elastase (0.3 U/mL, 200 nM) for 2.5 h, e;
cell layer treated with neutrophil elastase (0.3 U/mL,
200 nM) 2 h post wounding.
Figure S2. Immunostaining of PAR-2 in 16HBE 14o
cell layers. a; confluent cell layer, b; cell layer 2 hours post
wounding, c; cell layer treated with neutrophil elastase
(0.3 U/mL, 200 nM) for 2.5 h, d & e; cell layer treated with
neutrophil elastase (0.3 U/mL, 200 nM) 2 h post wounding.
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